Implantable particles for the treatment of gastroesophageal reflux disease
US7060298B2 · kind B2 · utility
26Cited by
20References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 28, 2001 |
| Grant date | Jun 13, 2006 |
| Priority date | — |
| Expiry date | Dec 28, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention encompasses the treatment of urinary incontinence, gastroesophageal reflux disease and the amelioration of skin wrinkles using biocompatible hydrophilic cationic microparticles and a cell adhesion promoter.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.